Every CRO out there will tell you they’re site-centric, and on pitch decks, they use the right buzzwords to prove it.
Curious. Collaborative. Dependable. Problem-solvers. Sound familiar?
That’s great in theory, but when timelines are tight, PIs are stressed, and enrollment numbers are down, do they really have the site relationships to get you through?
At Rho, when it comes to being site-centric, it’s not just a talking point, but it’s a value built into our work. We know when sites are clicking, you get faster feasibility responses, high site selection, repeat site participation, and, more importantly, your desired outcomes.
Case Study 2 from the Site Cohesion Hypothesis offers a good example of this in action.
Let’s Translate the CRO Site Lingo
Clinical trials have no shortage of moving parts, but when site relationships are strong, the pieces tend to fall into place a little easier. For us, we stepped up when it mattered most during a global Phase II/III, atopic dermatitis study. There were significant delays due to initial denial by CTIS in Europe, the sponsor was frustrated, and European sites were unavailable for over six months, even though they were expected to carry enrollment. Plans were thrown out the window. Enter Rho’s site expertise.
See how other CROs may stack up against the Cohesion Effect in this trial.
1. CRO says they’re “site–centric” and they prioritize site relationships.
Reality: They send sites templated updates and provide generic support from afar. Feedback loops disappear, sites are forced to figure things out on their own, and sites become disengaged in the trial. Dropout rates spike and chaos follows.
The Cohesion Effect: Strong site relationships translated into measurable benefits, salvaging a study that was at risk of collapsing—without timeline slippage. The feasibility models were quickly reworked, new countries were added, and we brought on a recruitment vendor to help sites with the final enrollment push. Our strength was in knowing the project deeply, communicating with sites and sponsors clearly, and making the experience as pleasant and productive as possible for everyone involved. It wasn’t “them” and “us”. We were all on the same team with the same goals.
2. CRO might claim they’re collaborative, and they listen and share ownership.
Reality: They drive decisions without listening to feedback. While site input is acknowledged, it is rarely acted on. Sites feel like their opinion doesn’t matter, and the CRO is not making them feel seen and heard. Trust falters and the relationship collapses.
The Cohesion Effect: Our approach to site relationships is rooted in human connection, treating our site partners not as numbers but as people. In this scenario, Rho CRAs were available to support, proactively managed questions and concerns, and maintained clear communication. This streamlined operations and preserved site motivation throughout the study. As it turned out, our culture of care, understanding, and trust helped us navigate the challenges and thrive in them with stronger bonds.
3. CRO promises they’re adaptable and willing to support sites no matter what.
Reality: They tell sites they are with them in any circumstance. During the trial, when problems arise, they say, “we’ll look into it,” and hope that everything resolves itself. No communication. No action. No endless support for sites, PIs, and study participants.
The Cohesion Effect: When sites faced adversity during the study, our CRAs and CTLs stepped in with a team-first mindset. We offered hands-on support and clear communication, providing personalized feedback and guidance to sites. To address underperformance, we deployed a site liaison to conduct in-person visits. These visits reinforced the importance of the study, helped reset expectations, and, ultimately, improved engagement. We never turned away from sites when things got hard.
4. CRO pledges they are experienced and have the site relationships you need.
Reality: They approach sites like a transaction rather than a relationship. The CRO expects sites to join the study without a connection in place. Sites aren’t responding, enrollment is suffering, and timelines are changing, impacting plans and budgets.
The Cohesion Effect: Like on all projects, our site relationship experts jumped in right away with feasibility information based on the specific needs of the study. Leaning on our existing partnerships around the world, we guided country selection and site strategy, provided a competitive analysis for atopic dermatitis, and presented all the data to the sponsor clearly. Working efficiently and keeping an eye on the details, we managed enrollment, communicated with sites, and met the threshold the sponsor approved. Despite the unexpected added countries, expanded scope, and budget changes, the team hit the original timeline. After stepping in during massive delays, we gained sponsor and site confidence from the start—and maintained it until the end.
Site-centricity is more than the right idea—it’s the right strategy. For this global Phase II/III study, the Rho team demonstrated what strong site engagement can lead to: Through smart site selection, nimbleness, and cultural sensitivity, we worked with sites to create the kind of cohesion that drove results. And that’s what makes us different.